A negative prognostic value of plasma CSF1/M-CSF was seen in iCCA and GBC, further implicating tumor-associated macrophages and the interplay between inflammatory activity and tumor progression as a possible therapeutic target in BTC. The gene discussed is CSF1; the disease is infantile convulsions and choreoathetosis.